Log In
Or login using:
Sign Up
Or sign up using:
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock BLOOD CANCER UK RESEARCH's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteBLOOD CANCER UK RESEARCH
5-11 THEOBALDS ROAD, LONDON, WC1X 8SH
Unlock Report
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
BLOOD CANCER UK RESEARCH
Private Ltd By Guarantee w/o Share Cap
Active - Accounts Filed
17 October 1962
72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering
Available to 03 Nov 2025. Next accounts due by 31 Dec 2026
Is BLOOD CANCER UK RESEARCH in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Ms Jean Liao | Director | ||
| Ms Megha Kansal | Director | ||
| Mr Matthew Dominic Wilson | Director | ||
| Professor Claire Nicola Harrison | Director | ||
| Mr Fraser Wilson | Director | ||
| Ms Juliet Helen Hillier | Director | ||
| Professor Christine Joyce Harrison | Director | ||
| Mr Alastair Stirling Boyle | Director | ||
| Mr Claude Manuel Littner | Director | ||
| Ms Jasmine Iona Handford | Director | ||
| Ms Louise Morgan Lai | Director | ||
| Mr Amir Shah Sethu | Director | ||
| Mr Nils Wieboldt | Company Secretary |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
0
Total Satisfied
1
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Barclays Bank PLC | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £4,269,000.00 | £2,662,000.00 | £3,599,000.00 | £6,039,000.00 | £3,344,000.00 |
| Net Worth | £19,902,000.00 | £19,822,000.00 | £16,804,000.00 | £12,337,000.00 | £12,436,000.00 |
| Total Current Liabilities | £10,587,000.00 | £9,258,000.00 | £8,144,000.00 | £9,365,000.00 | £9,645,000.00 |
| Total Current Assets | £5,730,000.00 | £5,623,000.00 | £6,156,000.00 | £6,987,000.00 | £5,369,000.00 |
Frequently Asked Questions about BLOOD CANCER UK RESEARCH
Detailed answers about BLOOD CANCER UK RESEARCH, including incorporation, status, business activity, and accounts information.
When was BLOOD CANCER UK RESEARCH founded?
BLOOD CANCER UK RESEARCH was officially incorporated on 17 October 1962 and is registered under company number 00738089. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BLOOD CANCER UK RESEARCH?
Private Ltd By Guarantee w/o Share Cap. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BLOOD CANCER UK RESEARCH?
BLOOD CANCER UK RESEARCH's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BLOOD CANCER UK RESEARCH do?
BLOOD CANCER UK RESEARCH operates in the following sector: 72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is BLOOD CANCER UK RESEARCH's registered address?
The registered office address of BLOOD CANCER UK RESEARCH is 5-11, Theobalds Road, London, Camden, WC1X 8SH. This is the official address filed with Companies House for legal and statutory correspondence.
Is BLOOD CANCER UK RESEARCH financially stable?
Based on the latest accounts up to 03 Nov 2025, BLOOD CANCER UK RESEARCH has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 Dec 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.